 <h1>Anakinra Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of anakinra include:</b> infection, antibody development, and inflammation at injection site. <b>Other side effects include:</b> neutropenia.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to anakinra: subcutaneous solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, anakinra may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking anakinra:</p><p>
<i>More common</i>
</p><ul>
<li>Diarrhea</li>
<li>fever or chills</li>
<li>headache</li>
<li>itching, pain, redness, swelling, tenderness or warmth on the skin</li>
<li>joint pain</li>
<li>muscle aches and pains</li>
<li>nausea or vomiting</li>
<li>runny nose or sneezing</li>
<li>sore throat</li>
</ul><p>
<i>Less common or rare</i>
</p><ul>
<li>Difficulty with swallowing</li>
<li>hives, itching, or rash</li>
<li>swelling of the face or lips</li>
<li>unusual bruising or bleeding</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Dizziness</li>
<li>fast heartbeat</li>
<li>hives or welts</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips or tongue</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of anakinra may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Abdominal or stomach pain</li>
<li>bleeding, blistering, burning, coldness, discoloration of skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site</li>
<li>difficulty with moving</li>
<li>headache</li>
<li>muscle aches or stiffness</li>
</ul><p>
<!-- end subcutaneous solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to anakinra: subcutaneous solution</i></p><h3>General</h3><p>The most serious side effects have included infections and neutropenia, while the most common side effects have included injection site reactions.<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site reaction (71%) (including erythema, ecchymosis, inflammation, and pain)<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Neutropenia, decreased total white blood cell count, decreased platelets </p>
<p><b>Frequency not reported</b>: small increases in the eosinophil differential percentage<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Vomiting (14%)</p>
<p><b>Common</b> (1% to 10%): Nausea, diarrhea, abdominal pain<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Upper respiratory tract infection (19%), nasopharyngitis (11%)</p>
<p><b>Common</b> (1% to 10%): Sinusitis, bronchitis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (12%)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthralgia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Worsening of RA (19%), pyrexia (11%)<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Hepatic enzyme increased</p>
<p><b>Frequency not reported</b>: Non-infectious hepatitis, elevations of transaminases<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Allergic reactions (including anaphylactic reactions), angioedema, urticaria, pruritus</p>
<p><b>Frequency not reported</b>: Rash<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Serious infections (primarily bacterial) (e.g., cellulitis, pneumonia, bone and joint infections), influenza-like symptoms</p>
<p><b>Frequency not reported</b>: Development of immunogenicity<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Frequency not reported</b>: Increased rate of lymphoma<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. Available from: URL: http://www.appco.com.au/appguide/default.asp."   ([2006]):</p><p id="ref_3">3. "Product Information. Kineret (anakinra)." Amgen, Thousand Oaks, CA. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>What are the new drugs for the treatment of rheumatoid arthritis (RA)?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about anakinra</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>9 Reviews</li>
<li>Drug class: antirheumatics</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Anakinra Subcutaneous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Kineret</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Still's Disease</li>
<li>Cryopyrin-Associated Periodic Syndromes</li>
<li>Schnitzler Syndrome</li>
<li>Rheumatoid Arthritis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to anakinra: subcutaneous solution</i></p><h3>General</h3><p>The most serious side effects have included infections and neutropenia, while the most common side effects have included injection site reactions.<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site reaction (71%) (including erythema, ecchymosis, inflammation, and pain)<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Neutropenia, decreased total white blood cell count, decreased platelets </p><p><b>Frequency not reported</b>: small increases in the eosinophil differential percentage<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Vomiting (14%)</p><p><b>Common</b> (1% to 10%): Nausea, diarrhea, abdominal pain<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Upper respiratory tract infection (19%), nasopharyngitis (11%)</p><p><b>Common</b> (1% to 10%): Sinusitis, bronchitis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (12%)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthralgia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Worsening of RA (19%), pyrexia (11%)<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Hepatic enzyme increased</p><p><b>Frequency not reported</b>: Non-infectious hepatitis, elevations of transaminases<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Allergic reactions (including anaphylactic reactions), angioedema, urticaria, pruritus</p><p><b>Frequency not reported</b>: Rash<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Serious infections (primarily bacterial) (e.g., cellulitis, pneumonia, bone and joint infections), influenza-like symptoms</p><p><b>Frequency not reported</b>: Development of immunogenicity<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Frequency not reported</b>: Increased rate of lymphoma<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. Available from: URL: http://www.appco.com.au/appguide/default.asp."   ([2006]):</p><p id="ref_3">3. "Product Information. Kineret (anakinra)." Amgen, Thousand Oaks, CA. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What are the new drugs for the treatment of rheumatoid arthritis (RA)?</li>
</ul><h2>More about anakinra</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>9 Reviews</li>
<li>Drug class: antirheumatics</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Anakinra Subcutaneous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Still's Disease</li>
<li>Cryopyrin-Associated Periodic Syndromes</li>
<li>Schnitzler Syndrome</li>
<li>Rheumatoid Arthritis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>